Earnings, Q1 FY2026
Q1 2026 revenue up 10%, net profit up 90%, with strong demand and margin improvement expected.
Med Life SA
No trades
No trades
Documents
Earnings
2026
May 29, 2026
2025
Earnings, Q4 FY2025
Turnover rose 17% to RON 3.17bn, with EBITDA up 16% and major expansion projects completed.
Earnings, Q3 FY2025
Turnover up 19.5%, EBITDA up 20.4%, but net profit down 88% on FX losses; hospitals led growth.
Earnings, Q2 FY2025
20% revenue growth and robust EBITDA, but FX losses and fiscal changes impact net results.
Earnings, Q1 FY2025
Q1 2025 revenue up 20% YoY, with robust growth in hospitals, labs, and tech-driven expansion.
2024
Earnings, Q4 FY2024
Strong 2024 growth with margin gains, new hospitals, and prudent expansion plans for 2025.
Earnings, Q3 FY2024
Revenue up 24% and net profit up 8x, with margin and leverage improvements.
Earnings, Q2 FY2024
MedLife delivered robust H1 2024 growth, with revenue up 24% and EBITDA margin at 16%.
Earnings, Q1 FY2024
2023
Earnings, Q4 FY2023
Earnings, Q3 FY2023
Earnings, Q2 FY2023
Earnings, Q1 FY2023
2022
Earnings, Q4 FY2022
Earnings, Q3 FY2022
Earnings, Q2 FY2022
Earnings, Q1 FY2022